codice protocollo
TATA

Extensive molecular profiling of radically resecate colon cancer patients enrolled in the phase III randomized TOSCA trial on adjuvant treatment duration.

data di chiusura
venerdì 16 dicembre 2022
sperimentatore principale
Nicoletta Pella
allegati